Key result
Cilostazol combined with aspirin resulted in 0% stent thrombosis, mortality, or major vascular complications at six months after stent implantation.
Why the study?
Does cilostazol combined with aspirin prevent stent thrombosis and complications in patients after stent implantation?
Population
85 consecutive patients with 93 lesions undergoing elective, bailout, or primary stent implantation in a…
Design
Cohort
Follow-up
six months
Authors
Loading...
May support cilostazol-aspirin post-stenting; hypothesis-generating and requires randomized confirmation before practice change.
Cohort (n=85)
No
Does cilostazol combined with aspirin prevent stent thrombosis and complications in patients after stent implantation?
Cilostazol combined with aspirin showed no stent thrombosis or major clinical events at six months after coronary stent implantation, suggesting it is a safe and effective antiplatelet regimen.
Yoshitomi et al. (1998) conducted a cohort in stent implantation (n=85). Cilostazol and aspirin was evaluated on Stent thrombosis, major and minor complications, and side effects. Cilostazol combined with aspirin resulted in 0% stent thrombosis, mortality, or major vascular complications at six months after stent implantation.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: